Future Opportunities in Cancer Nanotechnology-NCI Strategic Workshop Report

被引：29
作者：
Grodzinski, Piotr [1 ]
Farrell, Dorothy [1 ]
机构：
[1] NCI, Off Canc Nanotechnol Res, Bethesda, MD 20892 USA
来源：
CANCER RESEARCH | 2014年 / 74卷 / 05期
关键词：
NANOPARTICLES; DELIVERY;
D O I：
10.1158/0008-5472.CAN-13-2787
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
There has been significant progress in utilizing nanotechnology in several areas of cancer care, including in vitro diagnostics, imaging, and therapy. The National Cancer Institute, which currently supports an array of research activities in cancer nanotechnology, convened a strategic workshop to explore the most promising directions and areas for future resource investment. The major discussion points as well as the opportunities identified are presented herein. (C) 2014 AACR.
引用
收藏
页码：1307 / 1310
页数：4
相关论文
共 10 条
  • [1] Nanomedicine(s) under the Microscope
    Duncan, Ruth
    Gaspar, Rogerio
    [J]. MOLECULAR PHARMACEUTICS, 2011, 8 (06) : 2101 - 2141
  • [2] Micro-NMR for Rapid Molecular Analysis of Human Tumor Samples
    Haun, Jered B.
    Castro, Cesar M.
    Wang, Rui
    Peterson, Vanessa M.
    Marinelli, Brett S.
    Lee, Hakho
    Weissleder, Ralph
    [J]. SCIENCE TRANSLATIONAL MEDICINE, 2011, 3 (71)
  • [3] Preclinical Development and Clinical Translation of a PSMA-Targeted Docetaxel Nanoparticle with a Differentiated Pharmacological Profile
    Hrkach, Jeffrey
    Von Hoff, Daniel
    Ali, Mir Mukkaram
    Andrianova, Elizaveta
    Auer, Jason
    Campbell, Tarikh
    De Witt, David
    Figa, Michael
    Figueiredo, Maria
    Horhota, Allen
    Low, Susan
    McDonnell, Kevin
    Peeke, Erick
    Retnarajan, Beadle
    Sabnis, Abhimanyu
    Schnipper, Edward
    Song, Jeffrey J.
    Song, Young Ho
    Summa, Jason
    Tompsett, Douglas
    Troiano, Greg
    Hoven, Tina Van Geen
    Wright, Jim
    LoRusso, Patricia
    Kantoff, Philip W.
    Bander, Neil H.
    Sweeney, Christopher
    Farokhzad, Omid C.
    Langer, Robert
    Zale, Stephen
    [J]. SCIENCE TRANSLATIONAL MEDICINE, 2012, 4 (128)
  • [4] Targeted polymeric therapeutic nanoparticles: design, development and clinical translation
    Kamaly, Nazila
    Xiao, Zeyu
    Valencia, Pedro M.
    Radovic-Moreno, Aleksandar F.
    Farokhzad, Omid C.
    [J]. CHEMICAL SOCIETY REVIEWS, 2012, 41 (07) : 2971 - 3010
  • [5] Challenges and Key Considerations of the Enhanced Permeability and Retention Effect for Nanomedicine Drug Delivery in Oncology
    Prabhakar, Uma
    Maeda, Hiroshi
    Jain, Rakesh K.
    Sevick-Muraca, Eva M.
    Zamboni, William
    Farokhzad, Omid C.
    Barry, Simon T.
    Gabizon, Alberto
    Grodzinski, Piotr
    Blakey, David C.
    [J]. CANCER RESEARCH, 2013, 73 (08) : 2412 - 2417
  • [6] Efficiency of siRNA delivery by lipid nanoparticles is limited by endocytic recycling
    Sahay, Gaurav
    Querbes, William
    Alabi, Christopher
    Eltoukhy, Ahmed
    Sarkar, Sovan
    Zurenko, Christopher
    Karagiannis, Emmanouil
    Love, Kevin
    Chen, Delai
    Zoncu, Roberto
    Buganim, Yosef
    Schroeder, Avi
    Langer, Robert
    Anderson, Daniel G.
    [J]. NATURE BIOTECHNOLOGY, 2013, 31 (07) : 653 - U119
  • [7] Single-cell proteomic chip for profiling intracellular signaling pathways in single tumor cells
    Shi, Qihui
    Qin, Lidong
    Wei, Wei
    Geng, Feng
    Fan, Rong
    Shin, Young Shik
    Guo, Deliang
    Hood, Leroy
    Mischel, Paul S.
    Heath, James R.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2012, 109 (02) : 419 - 424
  • [8] Steenblock ER, 2009, EXPERT OPIN BIOL TH, V9, P451, DOI [10.1517/14712590902849216 , 10.1517/14712590902849216]
  • [9] Cancer nanomedicines: So many papers and so few drugs!
    Venditto, Vincent J.
    Szoka, Francis C., Jr.
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 2013, 65 (01) : 80 - 88
  • [10] von Maltzahn G, 2011, NAT MATER, V10, P545, DOI [10.1038/nmat3049, 10.1038/NMAT3049]
1